Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury

被引:14
|
作者
Chen, Fanghong [1 ]
Zhang, Guanjian [1 ]
Cao, Yanli [1 ]
Payne, Ryan [1 ]
See, William A. [1 ]
机构
[1] Med Coll Wisconsin, Dept Urol, Milwaukee, WI 53226 USA
来源
JOURNAL OF UROLOGY | 2007年 / 178卷 / 05期
关键词
bladder; bladder neoplasms; Mycobacterium bovis; apoptosis;
D O I
10.1016/j.juro.2007.06.040
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: By inducing cell cycle arrest at the G1/S transition bacillus Calmette-Guerin has been shown to have a direct antiproliferative effect on urothelial carcinoma cell lines. In other systems cell cycle arrest has been shown to confer a relative state of apoptotic resistance. We assessed the effect of bacillus Calmette-Guerin on the susceptibility of urothelial carcinoma cells to apoptotic stimuli. Materials and Methods: The human UC cell lines T24 and 253J (American Type Cell Culture, Rockville, Maryland) were used to evaluate the effect of bacillus Calmette-Guerin or antibody mediated alpha 5 beta 1cross-linking on apoptosis and apoptotic sensitivity. Following treatment baseline apoptosis and the response to the apoptotic inducing agent camptothecin was evaluated using assays for caspase 3 activation and DNA fragmentation. Pharmacological blockade of signaling pathways known to be activated in response to bacillus Calmette-Guerin/alpha 5 beta 1 cross-linking was used to assess the role of these pathways in the bacillus Calmette-Guerin apoptotic response. A final series of experiments used the MTT assay to study the impact of bacillus Calmette-Guerin pretreatment on the cytotoxicity of the antineoplastic agent mitomycin C. Results: Treatment with bacillus Calmette-Guerin failed to induce apoptosis, as measured by caspase 3 activation or DNA laddering. Bacillus Calmette-Guerin pretreatment significantly inhibited the induction of apoptosis in response to camptothecin. These effects were reproduced by antibody mediated cross-linking of alpha 5 beta 1 integrin. Pharmacological inhibition of nuclear factor kappa B and/or AP1 signaling pathways reversed the anti-apoptotic effect of bacillus Calmette-Guerin. Mitomycin C cytotoxicity was significantly decreased by bacillus Calmette-Guerin pretreatment. Conclusions: Bacillus Calmette-Guerin exerts a direct anti-apoptotic effect on human urothelial carcinoma cell lines. The ability of antibody mediated cross-linking to reproduce the effect and the ability of signal transduction inhibitors to block it are consistent with a mechanism involving integrin mediated signaling. Apoptotic resistance represents a therapeutic target for modulating the response to bacillus Calmette-Guerin and it may have clinical implications in the sequencing of intravesical therapies.
引用
收藏
页码:2166 / 2170
页数:5
相关论文
共 50 条
  • [41] Activation of human dendritic cells by bacillus Calmette-Guerin
    Ramoner, R
    Rieser, C
    Herold, M
    Klocker, H
    Bartsch, G
    Stenzl, A
    Thurnher, M
    JOURNAL OF UROLOGY, 1998, 159 (05): : 1488 - 1492
  • [42] Additional bacillus Calmette-Guerin therapy for recurrent transitional cell carcinoma after an initial complete response
    Bui, TT
    Schellhammer, PF
    UROLOGY, 1997, 49 (05) : 687 - 690
  • [43] Fever of unknown origin in a patient treated with Bacillus Calmette-Guerin (BCG) for bladder urothelial carcinoma in situ
    Ghiringhelli, Paolo
    Macchi, Federica
    Ciola, Mariella
    Sala, Girolamo
    Valvo, Beatrice
    Agostinelli, Andrea
    Bellintani, Lorenzo
    Rizzo, Gaetano Emanuele
    Provisione, Michela
    Zaza, Michela
    Diana, Alessandro
    Ferrarese, Maurizio
    CLINICAL MANAGEMENT ISSUES, 2023, 17 (01) : 25 - 39
  • [44] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [45] A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder
    Li, Roger
    Sexton, Wade J.
    Dhillon, Jasreman
    Berglund, Anders
    Naidu, Shreyas
    Borjas, Gustavo
    Rose, Kyle
    Kim, Youngchul
    Wang, Xuefeng
    Conejo-Garcia, Jose R.
    Jain, Rohit K.
    Poch, Michael A.
    Spiess, Philippe E.
    Pow-Sang, Julio
    Gilbert, Scott M.
    Zhang, Jingsong
    CLINICAL CANCER RESEARCH, 2023, 29 (19) : 3875 - 3881
  • [46] Prostatic Urothelial Carcinoma: Is Transurethral Prostatectomy Necessary Before Bacillus Calmette-Guerin Immunotherapy? Editorial Comment
    Montie, James E.
    JOURNAL OF UROLOGY, 2009, 182 (05): : 2208 - 2208
  • [47] INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NONMUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER - PATTERNS OF USE, AND IMPACT ON OUTCOMES
    Azer, S.
    Ranasinghe, W.
    Webb, C.
    Lioufas, P. A.
    Cetti, R.
    Frydenberg, M.
    Bolton, D.
    Appu, S.
    Sengupta, S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 40 - 40
  • [48] Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma
    Taoka, Rikiya
    Kobayashi, Takashi
    Hidaka, Yu
    Abe, Hiroyasu
    Ito, Katsuhiro
    Kojima, Takahiro
    Kato, Minoru
    Kanda, Souhei
    Hatakeyama, Shingo
    Matsui, Yoshiyuki
    Matsushita, Yuto
    Naito, Sei
    Shiga, Masanobu
    Miyake, Makito
    Muro, Yusuke
    Nakanishi, Shotaro
    Kato, Yoichiro
    Shibuya, Tadamasa
    Hayashi, Tetsutaro
    Yasumoto, Hiroaki
    Yoshida, Takashi
    Uemura, Motohide
    Kamiyama, Manabu
    Morita, Satoshi
    Ogawa, Osamu
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Sugimoto, Mikio
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (03) : 107.e1 - 107.e9
  • [49] EVALUATION OF A BLOOD-BASED ASSAY TO PREDICT CLINICAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE BLADDER
    Rothberg, Michael B.
    Le, Wenjun
    Davis, Ronald L.
    Cui, Zheng
    JOURNAL OF UROLOGY, 2019, 201 (04): : E818 - E818
  • [50] Recombinant bacillus Calmette-Guerin in urothelial bladder cancer immunotherapy: current strategies
    Wang, Yonghua
    Yang, Meng
    Yu, Qinchao
    Yu, Lun
    Shao, Shixiu
    Wang, Xinsheng
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 85 - 93